Currently, there are 296.96M common shares owned by the public and among those 292.84M shares have been available to trade.
The company’s stock has a 5-day price change of 1.28% and 12.28% over the past three months. DT shares are trading -5.74% year to date (YTD), with the 12-month market performance up to 9.36% higher. It has a 12-month low price of $39.42 and touched a high of $61.41 over the same period. DT has an average intraday trading volume of 2.94 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.77%, 10.32%, and 5.13% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Dynatrace Inc (NYSE: DT) shares accounts for 97.72% of the company’s 296.96M shares outstanding.
It has a market capitalization of $15.36B and a beta (3y monthly) value of 1.06. The stock’s trailing 12-month PE ratio is 99.63, while the earnings-per-share (ttm) stands at $0.52. The company has a PEG of 9.72 and a Quick Ratio of 1.26 with the debt-to-equity ratio at 0.04. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.01% over the week and 1.83% over the month.
Earnings per share for the fiscal year are expected to increase by 6.98%, and 15.39% over the next financial year.
Looking at the support for the DT, a number of firms have released research notes about the stock. Piper Sandler stated their Neutral rating for the stock in a research note on June 27, 2024, with the firm’s price target at $50. Needham was of a view on April 01, 2024 that the stock is Hold, while Wolfe Research gave the stock Outperform rating on March 18, 2024, issuing a price target of $60. CapitalOne on their part issued Overweight rating on February 21, 2024.
